Neogenomics Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Neogenomics Inc. filed 6 open-market sales worth $1.0 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Aunan Greg D, Chief Accounting Officer, sold 20,000 shares at $16.07 on 4 August 2026, filed 6 August 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 4 August 2026 | Aunan Greg D | Chief Accounting Officer | Sale | 20,000 | $16.07 | $321,400 | Form 4 |
| 15 June 2026 | Tetrault Lynn A. | Director | Sale | 5,307 | $11.10 | $58,908 | Form 4 |
| 9 June 2026 | Tetrault Lynn A. | Director | Sale | 5,307 | $11.29 | $59,916 | Form 4 |
| 20 January 2026 | Stone Warren | Pres & Chief Operating Officer | Sale | 22,128 | $12.50 | $276,682 | Form 4 |
| 25 November 2025 | Olivo Alicia C | EVP, GC & Business Development | Sale | 20,916 | $12.00 | $250,992 | Form 4 |
| 16 October 2025 | Olivo Alicia C | EVP, GC & Business Development | Sale | 4,918 | $10.00 | $49,180 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Neogenomics Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.